ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology.
Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services.
By loading the video, you agree to YouTube's privacy policy.
Learn more
Licenses are available in a wide range of fields
- Pharmaceutical & Biotechnology
- CROs, CMOs & Tool Providers
- Companion Animal & Veterinary Applications
- Agriculture & Livestock applications
- Industrial & Synthetic Biology Applications
Some of our 100+ Licensees
Internal
Research
Research
Industrial Bio
Production
Production
CRO’s
CMO’s
CMO’s
Tools /
Reagents
Reagents
